Department of Pharmacy Practice

Rose Jung, Pharm.D., BCPS

Photo of Dr. Jung 

Visiting Associate Professor
Department of Pharmacy Practice

Frederic and Mary Wolfe Center 114D
Dr. Jung graduated from Rutgers University in 1993 with the Bachelors of Science in Pharmacy, and St. John’s University in 1996 with the Doctor of Pharmacy degree. She completed the Pharmacy Practice Residency and Critical Care and Infectious Diseases Pharmacotherapy Fellowship at The University of Illinois at Chicago. Thereafter, Dr. Jung was on faculty at the University of Colorado Health Sciences Center until moving to The University of Toledo in 2007.

Dr. Jung is a Board Certified Pharmacotherapy Specialist.  She is currently in a process of completing the Masters in Public Health degree at the Northwest Ohio Consortium for Public Health.  Dr. Jung is a member of the American College of Clinical Pharmacy and the Society of Infectious Disease Pharmacists.

Dr. Jung coordinates and lectures in Patient Care Rounds II and Introductions to Research Methods.  She also teaches in Professional Practice Development courses and in the Infectious Disease Pathophysiology and Pharmacotherapy course.

Dr. Jung has published book chapters, research papers, and critical reviews on infection and critical illness in a variety of peer-reviewed publications.  Recent publications are noted as follows.

Recent Publications

Khuder SA, Foos M, Herial NA, Mutgi AB, Khuder BS, Jung R.  Urban/rural differences in hospital admissions with multiple sclerosis in selected counties in Ohio 1999-2004.  Open Epidemiol J 2009;2:51-4.

Cappelletty DM, Jung R.  Anidulafungin and its role in candida infections.  Infect Drug Resist 2009; 2:51

Juang P, Fish DN, Jung R, MacLaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy. 2007 Jan;27(1):11-9.

Seo YS, Lee SH, Shin EK, Kim SJ, Jung R, HahnTW.  Pulsed-field gel electrophoresis genotyping of  Salmonella gallinarum and comparison with random amplified polymorphic DNA genotyping. Vet Microbiol 2006;115:349-57.

MacLaren R, Obritsch O, Sherman D, Jung R, Fish D.  Assessing Adherence to an Intravenous Pantoprazole Guideline. Journal of Pharmacy Technology  2006:2215-21.

Kiser T, Jung R, MacLaren R, Fish D.  Evaluation of Direct Thrombin Use in Patients with Proven or Suspected Heparin Induced Thrombocytopenia (HIT).  Pharmacotherapy  2005;12: 1736-45.

Obritsch MD, Fish DN, MacLaren R, Jung R.  Nosocomial Infections due to Multidrug Resistant Pseudomonas aeruginosa: A Focus on Epidemiology and Treatment Options.  Pharmacotherapy  2005;25:1353-64.

Kiser T, Fish DN, Obritsch, Jung R, MacLaren R, Parikh CR.  Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study.  Nephrology, Dialysis and Transplantation  2005:20:1813-20.

Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF.  Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist to reconstituted lyophilized formulation.  J Pharm Sci. 2005 94:382-96.

Jung R, Hussain M, Choi MK, Fish DF.  Synergistic activities of moxifloxacin alone and in combination with piperacillin/tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.  Antimicrob Agents Chemother 2004;48:1055-1057.

Jung R, Fish DN, Obritsch MD, MacLaren R.  Surveillance of Multi-Drug Resistant Pseudomonas aeruginosa in the Urban Tertiary-Care Teaching Hospital.  J Hosp Infect 2004;57:105-111.

Gotfried MH, Jung R, Messick CR, Rubinstein I, Garey KW, Rodvold KA, Danziger LH.  The beneficial impact of long-term clarithromycin therapy in subjects with corticosteroid-dependent asthma.  Curr Therap Res 2004;65:1-12.

MacLaren R, Gasper J, Jung R,  Vandivier RW,.  Rationalizing the Use of Exogenous Erythropoietin in Critically Ill Patients.  Clin Pharm Therap 2004;29:195-208.

Obritsch MD, MacLaren R, Jung R, Fish DN.  Effects of Continuous Vasopressin Infusion in Patients with Septic Shock. Ann Pharmacother 2004;38:1117-1122.

Obritsch MD, Bestul D, Jung R, Fish DN, MacLaren R.  Role of Vasopressin in Vasodilatory Septic Shock.  Pharmacother 2004;24:1050-1063.

Obritsch MD, Fish DN, MacLaren R Jung R.  Incidence of Multi-Drug Resistant Pseudomonas  aeruginosa in the United States, 1993-2002.  Antimicrob Agents Chemother 2004;48:4606-4610.

Jung R, Pendland SL, Martin SJ.  The effect of partial liquid ventilation with perfluorooctylbromide on bacterial growth. Chemother 2003;49(1-2):1-7.

Dugan HA, MacLaren R, Jung R.  Short-course antibiotic therapy for nosocomial pneumonia. J Clin Pharm Therap 2003; 28:1-6

Tesoro EP, Jung R, Messick CR, Martin SJ, Pendland SL.  In vitro evaluation of antibiotic combinations against hospital-acquired isolates of Stenotrophomonas maltophilia.  J Appl Res 2003; 3 (2):1-5

Fish DN, Choi MK, Jung R.  Synergistic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs.  J Antimicrob Chemother 2002;50:1045-1049.

Jung R, Pendland SL, Martin SJ.  Combined bactericidal activity of perfluorooctyl bromide and aminoglycosides against Pseudomonas aeruginosa.  J Antimicrob Chemother 2002;50:939-944.

Jung R, MacLaren R.  Proton pump inhibitors for the prevention of stress related mucosal bleeding in critically ill patients.  Ann Pharmacother 2002;36:1929-1937.

Neuhauser MM, JungR, Danziger LH, Pendland SL.  In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae.  Int J Antimicrob Agents 2002; 20:395-398.

Pendland SL, Neuhauser MM, Garey KW, Prause JL, Jung R.  Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration.  Diagn Microb Infect Dis 2002; 44:59-61.

MacLaren R, Jung R.  Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults.  Pharmacother 2002; 22(9):1140-1156.

Pendland SL, Jung R, Messick CR, Schriever CA, Patka J.  In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis. Diagn Micro Infect Dis.  2002; 43(2):149-156.

Jung R, LI DH, Pendland SL, Danziger LH.  Intracellular activity of ABT-773 and other antimicrobial agents  against Legionella pneumophila isolates. J Antimicrob Chemother 2002; 49: 857-861.

Pendland SL, Messick CR, Jung R. In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.  Diagn Microbiol Infect Dis 2002; 42:75-78.

Martin SJ, Jung R, Garvin CG.  A Risk-Benefit Assessment of Levofloxacin In Respiratory, Skin and Skin Structure, and Urinary Tract Infections.  Drug Safety 2001;24(3):199-222.

Jung R, Messick CR, Pendland SL.  Postantibiotic effect and bactericidal activity of clarithromycin/14-hydroxy clarithromycin against Bacteroides fragilis.  Antimicrob Agent Chemother.  2000;44(3):778-779.

Last Updated: 6/26/15